Riskpilot← Back to searchSign inGet full accessProDerma Clinic Oy
OYActiveY-tunnus 2849121-9Uudenmaankatu 44-E101Beauty care and other beauty treatment activities · NACE 9622Est. 2017— employeeswww.prodermaclinic.fi
Revenue 2024
EUR 236K
-9% vs 2023
EBITDA margin
16.0%
-22% vs 2023
Equity ratio
76.5%
Financial strength
Net profit 2024
EUR 28K
-24% vs 2023
| Revenue | EUR 236K | -9% |
| EBITDA | EUR 38K | -22% |
| Net profit | EUR 28K | -24% |
| Total assets | EUR 149K | -99% |
| Equity | EUR 114K | -99% |
| Employees | — | — |
Legal name
ProDerma Clinic Oy
Y-tunnus number
2849121-9
Legal form
Osakeyhtiö
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
12. elokuuta 2017
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Kauneudenhoitopalvelut, esteettiset toimenpiteet, täyteainehoidot, plastiikkakirurgisen sairaanhoitajan konsultointi, neuvontapalvelut, kauneudenhoitotuotteiden vienti, tuonti ja nettikauppa ja sijoitustoiminta. Yritys voi omistaa osakkeita, osuuksia ja kiinteistöjä.
Address
Uudenmaankatu 44-E101
Phone
+3580451230103
Email
susanna.tolonen@prodermaclinic.fi
Website
www.prodermaclinic.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 157 | 221 | 263 | 259 | 236 |
| Staff expenses | −26 | −37 | −31 | −40 | −44 |
| EBITDA | 5 | 32 | 51 | 49 | 38 |
| Depreciation & amort. | — | −1 | −0 | −0 | −0 |
| EBIT | 5 | 31 | 51 | 48 | 38 |
| Net financials | −1 | −2 | −1 | −2 | −1 |
| Profit before tax | 4 | 29 | 49 | 47 | 36 |
| Tax | 1 | 6 | 10 | 9 | 8 |
| Net profit | 4 | 23 | 39 | 37 | 28 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 27 | 106 | 131 | 14 213 | 149 |
| Equity | 8 | 31 | 66 | 9 560 | 114 |
| Long-term debt | — | 40 | 29 | 1 864 | 7 |
| Short-term debt | 18 | 35 | 36 | 2 789 | 28 |
| Total debt | 18 | 75 | 65 | 4 654 | 35 |
EBITDA margin
16.0%
This company
15.8%
Market median
+1% vs market
20202024
Equity ratio
76.5%
This company
38.2%
Market median
+100% vs market
20202024
Return on equity
24.9%
This company
18.4%
Market median
+35% vs market
20202024
Net profit margin
12.0%
This company
8.1%
Market median
+48% vs market
20202024
Asset turnover
1.59×
This company
1.12×
Market median
+42% vs market
20202024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HV Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2017 | |
| Chairperson | 2017 | |
| Board of Directors | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ProDerma Clinic Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hannu Veikko Manninen | Chief Executive Officer | 0 companies |
| Niilo Arne Ilmari Manninen | Board of Directors | 0 companies |
| Tiina Susanna Tolonen | Chairperson | 0 companies |
| Peppi Elvira Olivia Manninen | Board of Directors | 0 companies |